We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Thiazolidinediones: A novel class of drugs for the prevention of diabetic nephropathy?
- Authors
Zheng, F.; Guan, Y.
- Abstract
Diabetic nephropathy is the leading cause of end-stage renal disease. Novel preventive measures for diabetic renal complications are urgently needed. Miyazaki et al. report that rosiglitazone, a thiazolidinedione insulin sensitizer and a potent peroxisome proliferator-activated receptor γ agonist, not only effectively improves glycemic control but also halts progression of albuminuria in type 2 diabetic patients with early-stage diabetic nephropathy. These findings could offer a new prevention of diabetic nephropathy in insulin-resistant diabetic patients.Kidney International (2007) 72, 1301–1303. doi:10.1038/sj.ki.5002557
- Subjects
PEOPLE with diabetes; KIDNEY diseases; DIABETIC nephropathies; HYPOGLYCEMIC agents; PANCREATIC secretions; CHRONIC kidney failure
- Publication
Kidney International, 2007, Vol 72, Issue 11, p1301
- ISSN
0085-2538
- Publication type
Article
- DOI
10.1038/sj.ki.5002557